ĐÁNH GIÁ KẾT QUẢ ĐIỀU TRỊ THOÁI HÓA KHỚP GỐI NGUYÊN PHÁT GIAI ĐOẠN 2, 3 BẰNG LIỆU PHÁP TIÊM HUYẾT TƯƠNG GIÀU TIỂU CẦU TỰ THÂN TẠI THÁI BÌNH NĂM 2023-2024

Abstract

Background: Treatment of primary knee osteoarthritis stages 2 and 3 using autologous platelet-rich plasma (PRP) therapy has emerged as a new option in recent years. The damaged cartilage is regenerated and repaired through biological mechanisms, showing good results in treatment without adverse events or complications. Our study aims to evaluate the effectiveness of autologous PRP therapy for patients with primary knee osteoarthritis stages 2 and 3. Methods: This prospective descriptive study with an intervention but without a control group assesses the pre-and post-treatment effectiveness of 34 patients diagnosed with primary knee osteoarthritis stages 2 and 3, treated at Thai Binh University Hospital from January 2023 to December 2024. Results: Knee joint function improved, with VAS and Lequesne scores gradually decreasing, while the quality of life score increased after treatment. Conclusion: Autologous PRP therapy has demonstrated significant effectiveness in reducing pain levels, improving knee joint function, and enhancing the quality of life for patients with primary knee osteoarthritis stages 2 and 3.